Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRG2 | P18507 | 4/20 | 0.35 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.35 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.35 |
| ▸ | GABRA6 | Q16445 | 4/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.35 |
| ▸ | GABRA2 | P47869 | 3/20 | 0.35 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.35 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.35 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | JAK1 | P23458 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12295805 | 1.00 | GABRG2 (0.35) | GABRG2GABRB3GABRA5GABRA6GABRA1 | |
| SCHEMBL16229709 | 0.93 | GABRA1 (0.35) | GABRG2GABRB3GABRA5GABRA6GABRA1 | |
| SCHEMBL12295800 | 0.90 | GABRA5 (0.38) | GABRG2GABRB3GABRA5GABRA6GABRA1 | |
| SCHEMBL12373653 | 0.89 | GABRA1 (0.35) | GABRG2GABRB3GABRA1GABRA2GABRA3 | |
| SCHEMBL10202474 | 0.89 | GABRA1 (0.35) | GABRG2GABRB3GABRA1GABRA2GABRA3 | |
| SCHEMBL12328180 | 0.88 | KRAS (0.33) | KAT2BJAK1 | |
| SCHEMBL13087697 | 0.87 | GABRA1 (0.33) | GABRG2GABRB3GABRA1GABRA2GABRA3 | |
| SCHEMBL6126516 | 0.87 | CDK1 (0.33) | KAT2BJAK1 | |
| SCHEMBL22361269 | 0.87 | CDK1 (0.33) | KAT2BJAK1 | |
| SCHEMBL13087924 | 0.87 | CDK1 (0.33) | KAT2BJAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2398794-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2013-01-16 | — | — | EP | disclosed |
| WO-2012039717-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-29 | — | — | WO | disclosed |
| WO-2012018325-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-02-09 | — | — | WO | disclosed |